Hyperparathyroidism is an increased parathyroid hormone (PTH) l... - dofaq.com
hyperparathyroidism

Hyperparathyroidism is an increased parathyroid hormone (PTH) l...

wikipedia - 19 Sep 2016
Hyperparathyroidism is an increased parathyroid hormone (PTH) levels in the blood. This occurs either from the parathyroid glands inappropriately making too much PTH (primary hyperparathyroidism) or other events triggering increased production by the parathyroid glands (secondary hyperparathyroidism). Most people with primary disease have no symptoms at the time of diagnosis. In those with symptoms the most common is kidney stones with other potential symptoms including weakness, depression, bone pai
hyperparathyroidism

Amgen Gets EU Nod to Expand Hyperparathyroidism Drug Label

Nasdaq - 01 Sep 2017
Amgen, Inc. AMGN announced that the European Commission has approved the marketing application for a pediatric formulation (granules in capsule for opening) of Mimpara for the treatment of secondary hyperparathyroidism (sHPT). With this approval, the ...
hyperparathyroidism

Secondary Hyperparathyroidism Pipeline Insight, 2017

E News Access (press release) - 23 Sep 2017
Secondary Hyperparathyroidism- Competitive Landscape, Pipeline and Market Analysis, 2017, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the ...
hyperparathyroidism

Primary hyperparathyroidism often symptomatic in children

Healio - 28 Aug 2017
Children in China diagnosed with primary hyperparathyroidism are often symptomatic and may be at higher risk for rickets or osteomalacia compared with adults, according to findings published in Clinical Endocrinology. Ou Wang, MD, of the Key Laboratory ...
hyperparathyroidism

Efficacy of Surgery for Primary Hyperparathyroidism

Medical News Bulletin - 12 Sep 2017
The surgical removal of parathyroid glands has been shown to reduce the symptoms of primary hyperparathyroidism (pHPT) but since the condition ranges over a large spectrum it is difficult for clinicians to determine which patients would benefit the ...
hyperparathyroidism

Hyperparathyroidism Pipeline Insight, 2017

E News Access (press release) - 20 Sep 2017
Hyperparathyroidism- Competitive Landscape, Pipeline and Market Analysis, 2017, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for ...
hyperparathyroidism

Secondary Hyperparathyroidism Analysis 2017 to 2025

E News Access (press release) - 15 Sep 2017
Secondary Hyperparathyroidism- Competitive Landscape, Pipeline and Market Analysis, 2017, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the ...
hyperparathyroidism

Total Parathyroidectomy Procedures Similarly Efficacious

Renal and Urology News - 18 Sep 2017
Yanbing Zhou, MD, PhD, of Affiliated Hospital of Qingdao University in China, and collaborators reviewed 10 cohort studies and 1 randomized controlled trial published 1991 to 2016 comparing the procedures for refractory secondary hyperparathyroidism ...
hyperparathyroidism

Rockwell Medical Updates Progress on Calcitriol Commercial Launch

GlobeNewswire (press release) - 13 Sep 2017
Rockwell Medical is a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis.
hyperparathyroidism

Efficacy of Paricalcitol vs Other VDRAs Unclear

Renal and Urology News - 01 Sep 2017
A new systematic review and meta-analysis found no significant difference in the efficacy and safety of paricalcitol versus other vitamin D receptor activators (VDRAs) in the treatment of secondary hyperparathyroidism (SHPT) in dialysis patients based ...
hyperparathyroidism

Rockwell Medical Appoints John G. Cooper to Board of Directors

Markets Insider - 08 Sep 2017
Rockwell Medical is a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis.
hyperparathyroidism

Parathyroidectomy Associated With Morbidity, Mortality

Renal and Urology News - 14 Sep 2017
Studies have shown that parathyroidectomy reduces serum intact parathyroid hormone levels (iPTH) in patients with secondary hyperparathyroidism, but the clinical impact of the surgery has been less clear. A new study found that a small proportion of ...
hyperparathyroidism

The Often Missed Diagnosis of Primary Hyperparathyroidism

Medscape - 18 Aug 2017
We also need to remember that patients with hyperparathyroidism can have calcium levels that fluctuate during the day. One normal calcium doesn't mean that you can ignore an abnormal one. Next time you see a high calcium, consider including the PTH in ...

What's New